OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
We haven't written up this one. OpenAI News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- OpenAI acquires Orchestra Bio openai.com